Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000249784 | SCV000305744 | benign | not specified | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV000755336 | SCV000604715 | benign | Polycystic kidney disease, adult type | 2020-06-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000249784 | SCV000614503 | benign | not specified | 2017-07-20 | criteria provided, single submitter | clinical testing | |
Molecular Genetics of Inherited Kidney Disorders Laboratory, |
RCV001254315 | SCV001430267 | benign | Autosomal dominant polycystic kidney disease | 2019-01-01 | criteria provided, single submitter | research | |
Gene |
RCV001640495 | SCV001859400 | benign | not provided | 2019-09-26 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001291900 | SCV000592777 | benign | Polycystic kidney disease | no assertion criteria provided | clinical testing | The c.4674G>A, p.Thr1558Thr variant was identified in7.57% of 9015 control alleles in the Exome Aggregation Consortium (March 14, 2016). According to ACMG guidelines for variant classification based on allele frequency, category BA1, this variant is considered benign and has not been further reviewed (Richards 2015). |